psilocybinPapers
Papers about psilocybin
- papers
- 210
Newest first
51 to 100 of 210Every paper here, unless its row says otherwiseIndexed under psilocybin in PubMed; returned by a PubMed search for psilocybin
Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.
Psychiatry research2025PMID 39754904
Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers.
Progress in neuro-psychopharmacology & biological psychiatry2025PMID 39788410
Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis.
Clinical pharmacokinetics2025PMID 39812743
Catalyst for change: Psilocybin's antidepressant mechanisms-A systematic review.
Journal of psychopharmacology (Oxford, England)2025PMID 39829391
Acute effects of psilocybin on attention and executive functioning in healthy volunteers: a systematic review and multilevel meta-analysis.
Psychopharmacology2025PMID 39847068
Acute psilocybin and ketanserin effects on cerebral blood flow: 5-HT2AR neuromodulation in healthy humans.
Journal of cerebral blood flow and metabolism2025PMID 40007438
Results From a Long-Term Observational Follow-Up Study of a Single Dose of Psilocybin for a Treatment-Resistant Episode of Major Depressive Disorder.
The Journal of clinical psychiatry2025PMID 40047545
Side effects of microdosing lysergic acid diethylamide and psilocybin: A systematic review of potential physiological and psychiatric outcomes.
Neuropharmacology2025PMID 40058407
Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidépresseurs de la psychothérapie assistée par la psilocybine (PAP) chez les personnes non médicamentées à la sélection initiale et les personnes ayant arrêté les médicaments pour participer à l'étude.
Canadian journal of psychiatry2025PMID 40129307
Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.
Neuroscience and biobehavioral reviews2025PMID 40245969
Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.
Palliative & supportive care2025PMID 40259688
Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.
Psychopharmacology2025PMID 40266291
Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis.
International journal of psychiatry in medicine2025PMID 40279353
Dissociable effects of psilocybin and escitalopram for depression on processing of musical surprises.
Molecular psychiatry2025PMID 40281226Indexed under psilocybin in PubMed
Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression.
The American journal of psychiatry2025PMID 40329640Indexed under psilocybin in PubMed
Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.
Neuroscience and biobehavioral reviews2025PMID 40456393
Long-term outcomes of single-dose psilocybin for U.S. military Veterans with severe treatment-resistant depression - 12-month data from an open-label pilot study.
Journal of affective disorders2025PMID 40499827
The effects of psilocybin therapy versus escitalopram on cognitive bias: A secondary analysis of a randomized controlled trial.
European neuropsychopharmacology2025PMID 40554997Indexed under psilocybin in PubMed
Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.
Journal of affective disorders2025PMID 40684956
Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials.
Eating and weight disorders2025PMID 40730892
Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis.
JAMA network open2025PMID 40736734
The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: a Survey Based Experiment.
The International journal on drug policy2025PMID 40743946
A dose of therapy with psilocybin - A meta-analysis of the relationship between the amount of therapy hours and treatment outcomes in psychedelic-assisted therapy.
General hospital psychiatry2025PMID 40782561
Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial.
General hospital psychiatry2025PMID 40858059
Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.
Acta neuropsychiatrica2025PMID 40899152
Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial.
PLoS medicine2025PMID 40972137
Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.
Progress in neuro-psychopharmacology & biological psychiatry2025PMID 41138900
Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.
Translational psychiatry2025PMID 41257994Indexed under psilocybin in PubMed
Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trial.
Progress in neuro-psychopharmacology & biological psychiatry2025PMID 41285295
The Relationship Between Participant Pretreatment Clinical Presentation and the Quality of Psilocybin Experience: A Retrospective Analysis.
Journal of clinical psychopharmacology2025PMID 41362124
Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.
Psychological medicine2024PMID 37264814Indexed under psilocybin in PubMed
Psilocybin's Potential Mechanisms in the Treatment of Depression: A Systematic Review.
Journal of psychoactive drugs2024PMID 37385217
The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review.
The Annals of pharmacotherapy2024PMID 37902038
Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review.
Journal of neurochemistry2024PMID 38019032
Neural Mechanisms of Resting-State Networks and the Amygdala Underlying the Cognitive and Emotional Effects of Psilocybin.
Biological psychiatry2024PMID 38185235
A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review.
Journal of affective disorders2024PMID 38244804
Assessing expectancy and suggestibility in a trial of escitalopram v. psilocybin for depression.
Psychological medicine2024PMID 38247730Indexed under psilocybin in PubMed
Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.
Scientific reports2024PMID 38316896Indexed under psilocybin in PubMed's chemical list; returned by a PubMed search for psilocybin
Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study.
Scientific reports2024PMID 38326432Indexed under psilocybin in PubMed's chemical list; returned by a PubMed search for psilocybin
Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.
Med (New York, N.Y.)2024PMID 38359838Indexed under psilocybin in PubMed's chemical list; returned by a PubMed search for psilocybin
The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.
PloS one2024PMID 38483940Indexed under psilocybin in PubMed's chemical list; returned by a PubMed search for psilocybin
Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression.
Journal of psychopharmacology (Oxford, England)2024PMID 38520045Indexed under psilocybin in PubMed
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.
Journal of affective disorders2024PMID 38570038
Psilocybin pulse regimen reduces cluster headache attack frequency in the blinded extension phase of a randomized controlled trial.
Journal of the neurological sciences2024PMID 38581739
Dynamic Functional Hyperconnectivity After Psilocybin Intake Is Primarily Associated With Oceanic Boundlessness.
Biological psychiatry2024PMID 38588855
Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.
JAMA network open2024PMID 38598236
The Promise of Therapeutic Psilocybin: An Evaluation of the 134 Clinical Trials, 54 Potential Indications, and 0 Marketing Approvals on ClinicalTrials.gov.
Drug design, development and therapy2024PMID 38618282
Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial.
Scientific reports2024PMID 38632313Indexed under psilocybin in PubMed's chemical list; returned by a PubMed search for psilocybin
The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin.
BMC psychiatry2024PMID 38658877
Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.
BMJ (Clinical research ed.)2024PMID 38692686